FDA.reportPublic FDA data

Turalio 125 MG Oral Capsule

RxCUI
2626399
RxNorm name
Turalio 125 MG Oral Capsule
Display name
Turalio 125 MG Oral Capsule
Full name
Turalio 125 MG Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TuralioPEXIDARTINIB HYDROCHLORIDEDaiichi Sankyo Inc.7b0ec4bf-b2ac-49ee-96af-7740ad3f2e162025-01-16Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2626399

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7b0ec4bf-b2ac-49ee-96af-7740ad3f2e16Turalio 125 MG Oral Capsule [PSN] · pexidartinib 125 MG Oral Capsule [Turalio] [SBD] · Turalio 125 MG Oral Capsule [SY]38These highlights do not include all the information needed to use TURALIO safely and effectively. See full prescribing information for TURALIO. TURALIO ® (pexidartinib) capsules, for oral use Initial U.S. Approval: 201920250116